MorphoSys AG buy elbawind
Summary
This prediction ended on 24.01.14 with a price of €63.80. The prediction had a final performance of 16.02%. elbawind has 50% into this predictionMorphoSys is a German biopharmaceutical company that develops innovative therapies for the treatment of cancer, autoimmune diseases, and other serious illnesses. The company specializes in developing monoclonal antibodies, which are highly specific and targeted therapies that recognize and bind to specific cancer cells or disease-causing proteins in the body. MorphoSys has a diverse pipeline of products in various stages of development, including several drugs that have shown promising results in clinical trials. The company is listed on the Frankfurt and NASDAQ stock exchanges and has a market capitalization of over $4 billion.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| MorphoSys AG | 0.300% | 0.300% | 216.998% | 2.527% |
| iShares Core DAX® | 4.094% | 4.888% | 17.421% | 22.413% |
| iShares Nasdaq 100 | 1.424% | -0.445% | 37.618% | 58.203% |
| iShares Nikkei 225® | -1.572% | -4.911% | 12.951% | 7.961% |
| iShares S&P 500 | 1.822% | 0.776% | 29.182% | 49.914% |
Comments by elbawind for this prediction
In the thread Morphosys AG diskutieren
klassisches Wendemanöver
Das Bild zeigt einen Ausbruch aus einer Konsolidierungsphase nach unten. Das geschah direkt an der unteren Kante eines Aufwärtskanals. Der langen Abwärtskerze von vorgestern folgte gestern ein Hammer mit einer Tiefstnotierung direkt an einer Unterstützung und heute die Bestätigung für die Kurswende in Form einer ziemlich großen Aufwärtskerze. Dieses Kerzenbild sollte den Aufschwung einleiten!